Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

Dolutegravir Cerebrospinal Fluid Diffusion in HIV-1-Infected Patients with Central Nervous System Impairment.

Gelé T, Furlan V, Taburet AM, Pallier C, Becker PH, Goujard C, Gasnault J, Barrail-Tran A, Chéret A.

Open Forum Infect Dis. 2019 Jun 3;6(6):ofz174. doi: 10.1093/ofid/ofz174. eCollection 2019 Jun.

2.

Clinical-care protocol for preventing mediastinitis after coronary artery bypass graft surgery: A quality improvement initiative from a private hospital.

Macedo TA, de Barros E Silva PGM, Machado AS, Ramos DL, Souza SF, Okada MY, de Souza RB, de Oliveira Jardim L, Garcia JCT, Furlan V.

J Card Surg. 2019 May;34(5):274-278. doi: 10.1111/jocs.14033. Epub 2019 Mar 29.

PMID:
30924558
3.

Inverse Molecular Docking as a Novel Approach to Study Anticarcinogenic and Anti-Neuroinflammatory Effects of Curcumin.

Furlan V, Konc J, Bren U.

Molecules. 2018 Dec 18;23(12). pii: E3351. doi: 10.3390/molecules23123351.

4.

Combining E-Nose and Lateral Flow Immunoassays (LFIAs) for Rapid Occurrence/Co-Occurrence Aflatoxin and Fumonisin Detection in Maize.

Ottoboni M, Pinotti L, Tretola M, Giromini C, Fusi E, Rebucci R, Grillo M, Tassoni L, Foresta S, Gastaldello S, Furlan V, Maran C, Dell'Orto V, Cheli F.

Toxins (Basel). 2018 Oct 16;10(10). pii: E416. doi: 10.3390/toxins10100416.

5.

PD-L1 Assays 22C3 and SP263 are Not Interchangeable in Non-Small Cell Lung Cancer When Considering Clinically Relevant Cutoffs: An Interclone Evaluation by Differently Trained Pathologists.

Munari E, Rossi G, Zamboni G, Lunardi G, Marconi M, Sommaggio M, Netto GJ, Hoque MO, Brunelli M, Martignoni G, Haffner MC, Moretta F, Pegoraro MC, Cavazza A, Samogin G, Furlan V, Mariotti FR, Vacca P, Moretta L, Bogina G.

Am J Surg Pathol. 2018 Oct;42(10):1384-1389. doi: 10.1097/PAS.0000000000001105.

PMID:
29901568
6.

Improvement in quality indicators using NCDR® registries: First international experience.

de Barros E Silva PGM, Ribeiro HB, Lopes RD, Macedo TA, Conejo F, do Amaral Baruzzi AC, Okada MY, Garcia JCT, Rodrigues MJ, Furlan V, Ribeiro EE.

Int J Cardiol. 2018 Sep 15;267:13-15. doi: 10.1016/j.ijcard.2018.05.102. Epub 2018 May 26.

PMID:
29861104
7.

Long-term outcome of liver transplantation in childhood: A study of 20-year survivors.

Martinelli J, Habes D, Majed L, Guettier C, Gonzalès E, Linglart A, Larue C, Furlan V, Pariente D, Baujard C, Branchereau S, Gauthier F, Jacquemin E, Bernard O.

Am J Transplant. 2018 Jul;18(7):1680-1689. doi: 10.1111/ajt.14626. Epub 2018 Jan 12.

8.

Management of Fruit Species in Urban Home Gardens of Argentina Atlantic Forest as an Influence for Landscape Domestication.

Furlan V, Pochettino ML, Hilgert NI.

Front Plant Sci. 2017 Sep 28;8:1690. doi: 10.3389/fpls.2017.01690. eCollection 2017.

9.

Intracerebral gene therapy in children with mucopolysaccharidosis type IIIB syndrome: an uncontrolled phase 1/2 clinical trial.

Tardieu M, Zérah M, Gougeon ML, Ausseil J, de Bournonville S, Husson B, Zafeiriou D, Parenti G, Bourget P, Poirier B, Furlan V, Artaud C, Baugnon T, Roujeau T, Crystal RG, Meyer C, Deiva K, Heard JM.

Lancet Neurol. 2017 Sep;16(9):712-720. doi: 10.1016/S1474-4422(17)30169-2. Epub 2017 Jul 14.

PMID:
28713035
10.

Production of docosahexaenoic acid by Aurantiochytrium sp. ATCC PRA-276.

Furlan VJM, Maus V, Batista I, Bandarra NM.

Braz J Microbiol. 2017 Apr - Jun;48(2):359-365. doi: 10.1016/j.bjm.2017.01.001. Epub 2017 Jan 20.

11.

Pharmacokinetics of Mycophenolic Acid and Dose Optimization in Children After Intestinal Transplantation.

Barau C, Mellos A, Chhun S, Lacaille F, Furlan V.

Ther Drug Monit. 2017 Feb;39(1):37-42. doi: 10.1097/FTD.0000000000000363.

PMID:
27898598
12.

Early reperfusion therapy in acute ischemic stroke after recent myocardial infarction.

Kuster GW, Baruzzi AC, Pacheco Ede P, Domingues RB, Pieruccetti M, Giacon LM, Garcia JC, Furlan V, Massaro AR.

Arq Neuropsiquiatr. 2016 Aug;74(8):690-1. doi: 10.1590/0004-282X20160099. No abstract available.

13.

Effect of exercise training on ventilatory efficiency in patients with heart disease: a review.

Prado DM, Rocco EA, Silva AG, Rocco DF, Pacheco MT, Furlan V.

Braz J Med Biol Res. 2016 Jun 20;49(7). pii: S0100-879X2016000700301. doi: 10.1590/1414-431X20165180. Review.

14.

Improving Indicators in a Brazilian Hospital Through Quality-Improvement Programs Based on STS Database Reports.

Barros e Silva PG, Baruzzi AC, Ramos DL, Okada MY, Garcia JC, Cardoso Fde A, Rodrigues MJ, Furlan V.

Braz J Cardiovasc Surg. 2015 Nov-Dec;30(6):660-3. doi: 10.5935/1678-9741.20150075.

15.

Effects of continuous vs interval exercise training on oxygen uptake efficiency slope in patients with coronary artery disease.

Prado DM, Rocco EA, Silva AG, Rocco DF, Pacheco MT, Silva PF, Furlan V.

Braz J Med Biol Res. 2016 Feb;49(2):e4890. doi: 10.1590/1414-431X20154890. Epub 2016 Feb 5.

16.

To what extent are medicinal plants shared between country home gardens and urban ones? A case study from Misiones, Argentina.

Furlan V, Kujawska M, Hilgert NI, Pochettino ML.

Pharm Biol. 2016 Sep;54(9):1628-40. doi: 10.3109/13880209.2015.1110600. Epub 2016 Feb 9.

PMID:
26857000
17.

Left Main Ostial Compression in a Patient with Pulmonary Hypertension: Dynamic Findings by IVUS.

Seabra LF, Ribeiro HB, de Barros e Silva PG, Rodrigues MJ, Spadaro AG, Conejo F, Godinho RR, Faig SM, de Macedo TA, Baptista Lde P, de Resende MV, Furlan V, Ribeiro EE.

Am J Case Rep. 2015 Dec 23;16:899-903.

18.

Impact of Chest Pain Protocol with Access to Telemedicine on Implementation of Pharmacoinvasive Strategy in a Private Hospital Network.

Macedo TA, de Barros E Silva PG, Simões SA, Okada MY, Garcia JC, Sampaio MC, Dantas RN Jr, Oliveira RP, Rocha LG, da Cunha Lopes BB, Frigini T, Furlan V.

Telemed J E Health. 2016 Jul;22(7):549-52. doi: 10.1089/tmj.2015.0178. Epub 2015 Dec 22.

PMID:
26693879
19.

Raltegravir Pharmacokinetics in Patients on Asunaprevir-Daclatasvir.

Barrail-Tran A, Vincent C, Furlan V, Rosa I, Rosenthal E, Cheret A, Molina JM, Taburet AM, Piroth L; ANRS HC30 QUADRIH Study Group.

Antimicrob Agents Chemother. 2015 Dec;59(12):7903-5. doi: 10.1128/AAC.01603-15. Epub 2015 Oct 5.

20.

Selective atrial vagal denervation guided by spectral mapping to treat advanced atrioventricular block.

Rivarola E, Hardy C, Sosa E, Hachul D, Furlan V, Raimundi F, Scanavacca M.

Europace. 2016 Mar;18(3):445-9. doi: 10.1093/europace/euv142. Epub 2015 Jun 11.

PMID:
26071235
21.

Paradoxical simultaneous regression and progression of lesions in a phase II study of everolimus in classic Kaposi sarcoma.

Mourah S, Porcher R, Battistella M, Kerob D, Guillot B, Jouary T, Agbalika F, Morinet F, Furlan V, Teisserenc HM, Dupin N, Lebbé C.

Br J Dermatol. 2015 Nov;173(5):1284-7. doi: 10.1111/bjd.13897. Epub 2015 Aug 19. No abstract available.

PMID:
25970141
22.

The influence of aerobic fitness status on ventilatory efficiency in patients with coronary artery disease.

Prado DM, Rocco EA, Silva AG, Silva PF, Lazzari JM, Assumpção GL, Thies SB, Suzaki CY, Puig RS, Furlan V.

Clinics (Sao Paulo). 2015 Jan;70(1):46-51. doi: 10.6061/clinics/2015(01)09.

23.

Worsening pneumonitis due to a pharmacokinetic drug-drug interaction between everolimus and voriconazole in a renal transplant patient.

Lecefel C, Eloy P, Chauvin B, Wyplosz B, Amilien V, Massias L, Taburet AM, Francois H, Furlan V.

J Clin Pharm Ther. 2015 Feb;40(1):119-20. doi: 10.1111/jcpt.12234. Epub 2014 Nov 24.

PMID:
25417855
24.

Resolution of an acute aortic syndrome with aortic valve insufficiency post-PCI.

de Barros e Silva PG, Aquino T, Resende MV, Richter I, Barros CM, Andrioli VG, Baruzzi AC, Medeiros CC, Furlan V.

Am J Case Rep. 2014 Nov 21;15:508-13. doi: 10.12659/AJCR.891301.

25.

Therapy with boceprevir or telaprevir in HIV/hepatitis C virus co-infected patients to treat recurrence of hepatitis C virus infection after liver transplantation.

Antonini TM, Furlan V, Teicher E, Haim-Boukobza S, Sebagh M, Coilly A, Bonhomme-Faivre L, Roque-Afonso AM, Vittecoq D, Samuel D, Taburet AM, Duclos-Vallée JC.

AIDS. 2015 Jan 2;29(1):53-8. doi: 10.1097/QAD.0000000000000516.

PMID:
25387314
26.

Nevirapine or efavirenz for tuberculosis and HIV coinfected patients: exposure and virological failure relationship.

Bhatt NB, Baudin E, Meggi B, da Silva C, Barrail-Tran A, Furlan V, Grinsztejn B, Bonnet M, Taburet AM; ANRS 12146/12214-CARINEMO Study Group.

J Antimicrob Chemother. 2015 Jan;70(1):225-32. doi: 10.1093/jac/dku348. Epub 2014 Sep 18.

27.

Effects of hydroxychloroquine on symptomatic improvement in primary Sjögren syndrome: the JOQUER randomized clinical trial.

Gottenberg JE, Ravaud P, Puéchal X, Le Guern V, Sibilia J, Goeb V, Larroche C, Dubost JJ, Rist S, Saraux A, Devauchelle-Pensec V, Morel J, Hayem G, Hatron P, Perdriger A, Sene D, Zarnitsky C, Batouche D, Furlan V, Benessiano J, Perrodeau E, Seror R, Mariette X.

JAMA. 2014 Jul 16;312(3):249-58. doi: 10.1001/jama.2014.7682.

PMID:
25027140
28.

Laser surface structuring of AZ31 Mg alloy for controlled wettability.

Gökhan Demir A, Furlan V, Lecis N, Previtali B.

Biointerphases. 2014 Jun;9(2):029009. doi: 10.1116/1.4868240.

PMID:
24985213
29.

Evaluation of the Society of Thoracic Surgeons score system for isolated coronary bypass graft surgery in a Brazilian population.

Ikeoka DT, Fernandes VA, Gebara O, Garcia JC, Barros e Silva PG, Rodrigues MJ, Furlan V, Baruzzi AC.

Rev Bras Cir Cardiovasc. 2014 Jan-Mar;29(1):51-8.

30.

Pharmacokinetics of rifampin and isoniazid in tuberculosis-HIV-coinfected patients receiving nevirapine- or efavirenz-based antiretroviral treatment.

Bhatt NB, Barau C, Amin A, Baudin E, Meggi B, Silva C, Furlan V, Grinsztejn B, Barrail-Tran A, Bonnet M, Taburet AM; ANRS 12146-CARINEMO Study Group.

Antimicrob Agents Chemother. 2014 Jun;58(6):3182-90. doi: 10.1128/AAC.02379-13. Epub 2014 Mar 24.

31.

Intravenous thrombolysis in basilar dissection: report of a good recovery and follow-up.

Kuster GW, Baruzzi AC, Ikeoka D, Pieruccetti M, Furlan V.

Arq Neuropsiquiatr. 2014 Jan;72(1):86-7. doi: 10.1590/0004-282X20130208. No abstract available.

32.

Intracerebral administration of adeno-associated viral vector serotype rh.10 carrying human SGSH and SUMF1 cDNAs in children with mucopolysaccharidosis type IIIA disease: results of a phase I/II trial.

Tardieu M, Zérah M, Husson B, de Bournonville S, Deiva K, Adamsbaum C, Vincent F, Hocquemiller M, Broissand C, Furlan V, Ballabio A, Fraldi A, Crystal RG, Baugnon T, Roujeau T, Heard JM, Danos O.

Hum Gene Ther. 2014 Jun;25(6):506-16. doi: 10.1089/hum.2013.238. Epub 2014 May 5.

PMID:
24524415
33.

Implementation of an institutional protocol for rational use of blood products and its impact on postoperative of coronary artery bypass graft surgery.

Silva PG, Ikeoka DT, Fernandes VA, Lasta NS, Silva DP, Okada MY, Izidoro BA, Garcia JC, Baruzzi AC, Furlan V.

Einstein (Sao Paulo). 2013 Jul-Sep;11(3):310-6. English, Portuguese.

34.

The key role of cultural preservation in maize diversity conservation in the argentine yungas.

Hilgert NI, Zamudio F, Furlan V, Cariola L.

Evid Based Complement Alternat Med. 2013;2013:732760. doi: 10.1155/2013/732760. Epub 2013 Sep 3.

35.

Successful anti-hepatitis C virus therapy with telaprevir in an HIV/hepatitis C virus co-infected patient with a severe recurrence of hepatitis C virus infection on the liver graft.

Antonini TM, Furlan V, Teicher E, Haim-Boukobza S, Sebagh M, Coilly A, Bonhomme-Faivre L, Peytavin G, Roque-Afonso AM, Vittecoq D, Samuel D, Taburet AM, Duclos-Vallée JC.

AIDS. 2013 Oct 23;27(16):2655-7. doi: 10.1097/01.aids.0000432539.77711.f4.

PMID:
23939241
36.

Characterization of binding of raltegravir to plasma proteins.

Barau C, Furlan V, Yazdanpanah Y, Fagard C, Molina JM, Taburet AM, Barrail-Tran A.

Antimicrob Agents Chemother. 2013 Oct;57(10):5147-50. doi: 10.1128/AAC.00625-13. Epub 2013 Jul 15.

37.

Tacrolimus dose requirement in pediatric liver transplantation: influence of CYP3A5 gene polymorphism.

Durand P, Debray D, Kolaci M, Bouligand J, Furlan V, Fabre M, Letierce A, Verstuyft C, Becquemont L.

Pharmacogenomics. 2013 Jul;14(9):1017-25. doi: 10.2217/pgs.13.87.

PMID:
23837476
38.

Practical management of boceprevir and immunosuppressive therapy in liver transplant recipients with hepatitis C virus recurrence.

Coilly A, Furlan V, Roche B, Barau C, Noël C, Bonhomme-Faivre L, Antonini TM, Roque-Afonso AM, Samuel D, Taburet AM, Duclos-Vallée JC.

Antimicrob Agents Chemother. 2012 Nov;56(11):5728-34. doi: 10.1128/AAC.01151-12. Epub 2012 Aug 20.

39.

Effect of continuous and interval exercise training on the PETCO2 response during a graded exercise test in patients with coronary artery disease.

Rocco EA, Prado DM, Silva AG, Lazzari JM, Bortz PC, Rocco DF, Rosa CG, Furlan V.

Clinics (Sao Paulo). 2012;67(6):623-8.

40.

Population pharmacokinetics of mycophenolic acid and dose optimization with limited sampling strategy in liver transplant children.

Barau C, Furlan V, Debray D, Taburet AM, Barrail-Tran A.

Br J Clin Pharmacol. 2012 Sep;74(3):515-24. doi: 10.1111/j.1365-2125.2012.04213.x.

41.

Optimization of the dosing regimen of mycophenolate mofetil in pediatric liver transplant recipients.

Barau C, Barrail-Tran A, Hemerziu B, Habes D, Taburet AM, Debray D, Furlan V.

Liver Transpl. 2011 Oct;17(10):1152-8. doi: 10.1002/lt.22364.

42.

SLCO1B1 genetic polymorphism influences mycophenolic acid tolerance in renal transplant recipients.

Michelon H, König J, Durrbach A, Quteineh L, Verstuyft C, Furlan V, Ferlicot S, Letierce A, Charpentier B, Fromm MF, Becquemont L.

Pharmacogenomics. 2010 Dec;11(12):1703-13. doi: 10.2217/pgs.10.132.

PMID:
21142914
43.

Evaluation of the Architect tacrolimus assay in kidney, liver, and heart transplant recipients.

Bazin C, Guinedor A, Barau C, Gozalo C, Grimbert P, Duvoux C, Furlan V, Massias L, Hulin A.

J Pharm Biomed Anal. 2010 Dec 1;53(4):997-1002. doi: 10.1016/j.jpba.2010.06.022. Epub 2010 Jun 26.

PMID:
20674215
44.

High concentration of raltegravir in semen of HIV-infected men: results from a substudy of the EASIER-ANRS 138 trial.

Barau C, Delaugerre C, Braun J, de Castro N, Furlan V, Charreau I, Gérard L, Lascoux-Combe C, Molina JM, Taburet AM.

Antimicrob Agents Chemother. 2010 Feb;54(2):937-9. doi: 10.1128/AAC.01261-09. Epub 2009 Dec 7.

45.

Quantification of raltegravir (MK0518) in human plasma by high-performance liquid chromatography with photodiode array detection.

Goldwirt L, Barrail-Tran A, Da Cruz M, Taburet AM, Furlan V.

J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Feb 1;878(3-4):456-60. doi: 10.1016/j.jchromb.2009.10.029. Epub 2009 Nov 11.

PMID:
19962949
46.

Rationale for monitoring cyclosporine concentration at 2 hours after administration in infants posttransplantation.

Furlan V, Lykavieris P, Maubert MA, Habes D, Debray D.

Transplant Proc. 2009 Oct;41(8):3333-4. doi: 10.1016/j.transproceed.2009.08.040.

PMID:
19857744
47.

Effect of coadministered HIV-protease inhibitors on tacrolimus and sirolimus blood concentrations in a kidney transplant recipient.

Barau C, Blouin P, Creput C, Taburet AM, Durrbach A, Furlan V.

Fundam Clin Pharmacol. 2009 Aug;23(4):423-5. doi: 10.1111/j.1472-8206.2009.00706.x.

PMID:
19709321
48.

Falsely elevated whole blood tacrolimus concentrations due to interference in an affinity column-mediated immunoassay method on Xpand dimension.

Barau C, Frangie C, Goujard C, Tribut O, Parant F, Taburet AM, Durrbach A, Furlan V.

Ther Drug Monit. 2009 Apr;31(2):267-8. doi: 10.1097/FTD.0b013e31819a7c19.

PMID:
19214146
49.

Comparison of 3 estimation methods of mycophenolic acid AUC based on a limited sampling strategy in renal transplant patients.

Hulin A, Blanchet B, Audard V, Barau C, Furlan V, Durrbach A, Taïeb F, Lang P, Grimbert P, Tod M.

Ther Drug Monit. 2009 Apr;31(2):224-32. doi: 10.1097/FTD.0b013e31819c077c.

PMID:
19214145
50.

Influence of CYP3A5 genetic polymorphism on tacrolimus daily dose requirements and acute rejection in renal graft recipients.

Quteineh L, Verstuyft C, Furlan V, Durrbach A, Letierce A, Ferlicot S, Taburet AM, Charpentier B, Becquemont L.

Basic Clin Pharmacol Toxicol. 2008 Dec;103(6):546-52. doi: 10.1111/j.1742-7843.2008.00327.x.

Supplemental Content

Loading ...
Support Center